Step-Up Treatment with Premixed Insulin Lispro-50/50 vs. Premixed Human Insulin Aspart-70/30: A Randomized Trial in Type 2 Diabetic Patients

被引：0
|
作者：
Ikeda, Shiori
Monden, Tsuyoshi
Matsumura, Mihoko
Shimizu, Hiroaki
Nakatani, Yuki
Miyashita, Yasushi
Domeki, Nozomi
Yanagi, Kazunori
Kasai, Kikuo
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A142 / A142
页数：1
相关论文
共 50 条
  • [21] Effects of Insulin Treatment with Glargine or Premixed Insulin Lispro Programs in Type 2 Diabetes Mellitus Patients: A Meta-analysis of Randomized Clinical Trials
    Sun, Di
    Zhang, Xu
    Hou, Xiu-xin
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (09) : 622 - 627
  • [22] Comparison of thrice daily 'high' vs. 'medium' premixed insulin aspart with respect to evening and overnight glycaemic control in patients with type 2 diabetes
    Ejskjaer, N
    Rasmussen, M
    Kamp, N
    Lindholm, A
    Christiansen, JS
    [J]. DIABETES OBESITY & METABOLISM, 2003, 5 (06): : 438 - 445
  • [23] Switching to biphasic insulin aspart 30/50/70 from biphasic human insulin 30/50 in patients with type 2 diabetes in normal clinical practice: observational study results (vol 28, pg 1017, 2012)
    Nobels, F.
    D'Hooge, D.
    Crenier, L.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (09) : 1546 - 1546
  • [24] Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US
    Ray, J. A.
    Valentine, W. J.
    Roze, S.
    Nicklasson, L.
    Cobden, D.
    Raskin, P.
    Garber, A.
    Palmer, A. J.
    [J]. DIABETES OBESITY & METABOLISM, 2007, 9 (01): : 103 - 113
  • [25] Insulin Degludec/Insulin Aspart (IDegAsp) Provides Superior FPG Control and Reduced Hypoglycaemia vs. Biphasic Insulin Aspart 30 (BIAsp 30) in Insulin-Naive Adults with Type 2 Diabetes in a Randomized Phase 3 Trial
    Franek, Edward
    Haluzik, Martin
    Canecki-Varzic, Silvija
    Sargin, Mehmet
    Macura, Stanislava
    Zacho, Jeppe
    Christiansen, Jens Sandahl
    [J]. DIABETES, 2014, 63 : A225 - A225
  • [26] Comparison of insulin lispro mix 25 with insulin lispro mix 50 as an insulin starter in Asian patients with type 2 diabetes: a phase 4, open-label, randomized trial (CLASSIFY study)
    Watada, Hirotaka
    Su, Qing
    Li, Peng Fei
    Iwamoto, Noriyuki
    Qian, Lei
    Yang, Wen Ying
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33 (01)
  • [27] Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study
    Amir Farshchi
    Rokhsareh Aghili
    Maryam Oskuee
    Marjan Rashed
    Sina Noshad
    Abbas Kebriaeezadeh
    Maryam Kia
    Alireza Esteghamati
    [J]. BMC Endocrine Disorders, 16
  • [28] Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study
    Farshchi, Amir
    Aghili, Rokhsareh
    Oskuee, Maryam
    Rashed, Marjan
    Noshad, Sina
    Kebriaeezadeh, Abbas
    Kia, Maryam
    Esteghamati, Alireza
    [J]. BMC ENDOCRINE DISORDERS, 2016, 16
  • [29] Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin
    Chen, Xi
    Xu, Yongping
    Zhang, Jianhua
    Shao, Shiyin
    Duan, Yanran
    Liu, Peiwen
    Shen, Liya
    Zhang, Jing
    Zeng, Jiaoe
    Lin, Mei
    Zhao, Shi
    Ma, Jianhua
    Zhao, Tao
    Hu, Juping
    Liao, Yong
    Chen, Xiaowen
    Hu, Shufang
    Xue, Yaoming
    Zeng, Zhaoyang
    He, Wentao
    Liu, Zhelong
    Li, Wenjun
    Liu, Liegang
    Yin, Ping
    Yu, Xuefeng
    [J]. ENDOCRINE PRACTICE, 2021, 27 (08) : 790 - 797
  • [30] Effects of Insulin Lispro Mix 25 and Insulin Lispro Mix 50 on Postprandial Glucose Excursion in Patients with Type 2 Diabetes: A Prospective, Open-Label, Randomized Clinical Trial
    Wei Li
    Fan Ping
    Lingling Xu
    Meicen Zhou
    Hongmei Li
    Yaxiu Dong
    Yuxiu Li
    [J]. Diabetes Therapy, 2018, 9 : 699 - 711
12345